Cargando…
Attribution to Heterogeneous Risk Factors for Breast Cancer Subtypes Based on Hormone Receptor and Human Epidermal Growth Factor 2 Receptor Expression in Korea
We conducted a heterogeneous risk assessment of breast cancer based on the hormone receptor (HR) and human epidermal growth factor receptor 2 (HER2) calculating the risks and population-based attributable fractions (PAFs) for modifiable and nonmodifiable factors. Using matched case–control study des...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998747/ https://www.ncbi.nlm.nih.gov/pubmed/27057831 http://dx.doi.org/10.1097/MD.0000000000003063 |
_version_ | 1782449997588987904 |
---|---|
author | Park, Boyoung Choi, Ji-Yeob Sung, Ho Kyung Ahn, Choonghyun Hwang, Yunji Jang, Jieun Lee, Juyeon Kim, Heewon Shin, Hai-Rim Park, Sohee Han, Wonshik Noh, Dong-Young Yoo, Keun-Young Kang, Daehee Park, Sue K. |
author_facet | Park, Boyoung Choi, Ji-Yeob Sung, Ho Kyung Ahn, Choonghyun Hwang, Yunji Jang, Jieun Lee, Juyeon Kim, Heewon Shin, Hai-Rim Park, Sohee Han, Wonshik Noh, Dong-Young Yoo, Keun-Young Kang, Daehee Park, Sue K. |
author_sort | Park, Boyoung |
collection | PubMed |
description | We conducted a heterogeneous risk assessment of breast cancer based on the hormone receptor (HR) and human epidermal growth factor receptor 2 (HER2) calculating the risks and population-based attributable fractions (PAFs) for modifiable and nonmodifiable factors. Using matched case–control study design from the Seoul Breast Cancer Study and the national prevalence of exposure, the risks and PAFs for modifiable and nonmodifiable factors were estimated for total breast cancers and subtypes. The attribution to modifiable factors was different for each subtype (luminal A, PAF = 61.4% [95% confidence interval, CI = 54.3%–69.8%]; luminal B, 21.4% [95% CI = 18.6–24.9%]; HER2-overexpression, 59.4% [95% CI = 47.8%–74.3%], and triple negative tumors [TNs], 27.1% [95% CI = 22.9%–32.4%)], and the attribution to the modifiable factors for the luminal A and HER2-overexpression subtypes was higher than that of the luminal B and TN subtypes (P heterogeneity ≤ 0.001). The contribution of modifiable reproductive factors to luminal A type in premenopausal women was higher than that of the other subtypes (18.2% for luminal A; 3.1%, 8.1%, and −3.1% for luminal B, HER2-overexpression, and TN subtypes, respectively; P heterogeneity ≤ 0.001). Physical activity had the highest impact preventing 32.6% of luminal A, 14.5% of luminal B, 38.0% of HER2-overexpression, and 26.9% of TN subtypes (P heterogeneity = 0.014). Total reproductive factors were also heterogeneously attributed to each breast cancer subtype (luminal A, 65.4%; luminal B, 24.1%; HER2-overexpression, 57.9%, and TN subtypes, −3.1%; P heterogeneity ≤ 0.001). Each pathological subtype of breast cancer by HRs and HER2 status may be associated with heterogeneous risk factors and their attributable risk, suggesting a different etiology. The luminal B and TN subtypes seemed to be less preventable despite intervention for alleged risk factors, even though physical activity had a high preventable potential against breast cancer. |
format | Online Article Text |
id | pubmed-4998747 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-49987472016-08-29 Attribution to Heterogeneous Risk Factors for Breast Cancer Subtypes Based on Hormone Receptor and Human Epidermal Growth Factor 2 Receptor Expression in Korea Park, Boyoung Choi, Ji-Yeob Sung, Ho Kyung Ahn, Choonghyun Hwang, Yunji Jang, Jieun Lee, Juyeon Kim, Heewon Shin, Hai-Rim Park, Sohee Han, Wonshik Noh, Dong-Young Yoo, Keun-Young Kang, Daehee Park, Sue K. Medicine (Baltimore) 4400 We conducted a heterogeneous risk assessment of breast cancer based on the hormone receptor (HR) and human epidermal growth factor receptor 2 (HER2) calculating the risks and population-based attributable fractions (PAFs) for modifiable and nonmodifiable factors. Using matched case–control study design from the Seoul Breast Cancer Study and the national prevalence of exposure, the risks and PAFs for modifiable and nonmodifiable factors were estimated for total breast cancers and subtypes. The attribution to modifiable factors was different for each subtype (luminal A, PAF = 61.4% [95% confidence interval, CI = 54.3%–69.8%]; luminal B, 21.4% [95% CI = 18.6–24.9%]; HER2-overexpression, 59.4% [95% CI = 47.8%–74.3%], and triple negative tumors [TNs], 27.1% [95% CI = 22.9%–32.4%)], and the attribution to the modifiable factors for the luminal A and HER2-overexpression subtypes was higher than that of the luminal B and TN subtypes (P heterogeneity ≤ 0.001). The contribution of modifiable reproductive factors to luminal A type in premenopausal women was higher than that of the other subtypes (18.2% for luminal A; 3.1%, 8.1%, and −3.1% for luminal B, HER2-overexpression, and TN subtypes, respectively; P heterogeneity ≤ 0.001). Physical activity had the highest impact preventing 32.6% of luminal A, 14.5% of luminal B, 38.0% of HER2-overexpression, and 26.9% of TN subtypes (P heterogeneity = 0.014). Total reproductive factors were also heterogeneously attributed to each breast cancer subtype (luminal A, 65.4%; luminal B, 24.1%; HER2-overexpression, 57.9%, and TN subtypes, −3.1%; P heterogeneity ≤ 0.001). Each pathological subtype of breast cancer by HRs and HER2 status may be associated with heterogeneous risk factors and their attributable risk, suggesting a different etiology. The luminal B and TN subtypes seemed to be less preventable despite intervention for alleged risk factors, even though physical activity had a high preventable potential against breast cancer. Wolters Kluwer Health 2016-04-08 /pmc/articles/PMC4998747/ /pubmed/27057831 http://dx.doi.org/10.1097/MD.0000000000003063 Text en Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the Creative Commons Attribution-NonCommercial License, where it is permissible to download, share and reproduce the work in any medium, provided it is properly cited. The work cannot be used commercially. http://creativecommons.org/licenses/by-nc/4.0 |
spellingShingle | 4400 Park, Boyoung Choi, Ji-Yeob Sung, Ho Kyung Ahn, Choonghyun Hwang, Yunji Jang, Jieun Lee, Juyeon Kim, Heewon Shin, Hai-Rim Park, Sohee Han, Wonshik Noh, Dong-Young Yoo, Keun-Young Kang, Daehee Park, Sue K. Attribution to Heterogeneous Risk Factors for Breast Cancer Subtypes Based on Hormone Receptor and Human Epidermal Growth Factor 2 Receptor Expression in Korea |
title | Attribution to Heterogeneous Risk Factors for Breast Cancer Subtypes Based on Hormone Receptor and Human Epidermal Growth Factor 2 Receptor Expression in Korea |
title_full | Attribution to Heterogeneous Risk Factors for Breast Cancer Subtypes Based on Hormone Receptor and Human Epidermal Growth Factor 2 Receptor Expression in Korea |
title_fullStr | Attribution to Heterogeneous Risk Factors for Breast Cancer Subtypes Based on Hormone Receptor and Human Epidermal Growth Factor 2 Receptor Expression in Korea |
title_full_unstemmed | Attribution to Heterogeneous Risk Factors for Breast Cancer Subtypes Based on Hormone Receptor and Human Epidermal Growth Factor 2 Receptor Expression in Korea |
title_short | Attribution to Heterogeneous Risk Factors for Breast Cancer Subtypes Based on Hormone Receptor and Human Epidermal Growth Factor 2 Receptor Expression in Korea |
title_sort | attribution to heterogeneous risk factors for breast cancer subtypes based on hormone receptor and human epidermal growth factor 2 receptor expression in korea |
topic | 4400 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998747/ https://www.ncbi.nlm.nih.gov/pubmed/27057831 http://dx.doi.org/10.1097/MD.0000000000003063 |
work_keys_str_mv | AT parkboyoung attributiontoheterogeneousriskfactorsforbreastcancersubtypesbasedonhormonereceptorandhumanepidermalgrowthfactor2receptorexpressioninkorea AT choijiyeob attributiontoheterogeneousriskfactorsforbreastcancersubtypesbasedonhormonereceptorandhumanepidermalgrowthfactor2receptorexpressioninkorea AT sunghokyung attributiontoheterogeneousriskfactorsforbreastcancersubtypesbasedonhormonereceptorandhumanepidermalgrowthfactor2receptorexpressioninkorea AT ahnchoonghyun attributiontoheterogeneousriskfactorsforbreastcancersubtypesbasedonhormonereceptorandhumanepidermalgrowthfactor2receptorexpressioninkorea AT hwangyunji attributiontoheterogeneousriskfactorsforbreastcancersubtypesbasedonhormonereceptorandhumanepidermalgrowthfactor2receptorexpressioninkorea AT jangjieun attributiontoheterogeneousriskfactorsforbreastcancersubtypesbasedonhormonereceptorandhumanepidermalgrowthfactor2receptorexpressioninkorea AT leejuyeon attributiontoheterogeneousriskfactorsforbreastcancersubtypesbasedonhormonereceptorandhumanepidermalgrowthfactor2receptorexpressioninkorea AT kimheewon attributiontoheterogeneousriskfactorsforbreastcancersubtypesbasedonhormonereceptorandhumanepidermalgrowthfactor2receptorexpressioninkorea AT shinhairim attributiontoheterogeneousriskfactorsforbreastcancersubtypesbasedonhormonereceptorandhumanepidermalgrowthfactor2receptorexpressioninkorea AT parksohee attributiontoheterogeneousriskfactorsforbreastcancersubtypesbasedonhormonereceptorandhumanepidermalgrowthfactor2receptorexpressioninkorea AT hanwonshik attributiontoheterogeneousriskfactorsforbreastcancersubtypesbasedonhormonereceptorandhumanepidermalgrowthfactor2receptorexpressioninkorea AT nohdongyoung attributiontoheterogeneousriskfactorsforbreastcancersubtypesbasedonhormonereceptorandhumanepidermalgrowthfactor2receptorexpressioninkorea AT yookeunyoung attributiontoheterogeneousriskfactorsforbreastcancersubtypesbasedonhormonereceptorandhumanepidermalgrowthfactor2receptorexpressioninkorea AT kangdaehee attributiontoheterogeneousriskfactorsforbreastcancersubtypesbasedonhormonereceptorandhumanepidermalgrowthfactor2receptorexpressioninkorea AT parksuek attributiontoheterogeneousriskfactorsforbreastcancersubtypesbasedonhormonereceptorandhumanepidermalgrowthfactor2receptorexpressioninkorea |